588367 Disclosed is a topical aqueous ophthalmic solution comprising 0.45 percent w/v ketorolac tromethamine, about 0.5 percent w/v carboxymethyl cellulose and no preservative.

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution which provides increased visual acuity in users and wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient which is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ke...

The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution which provides increased visual acuity in users and wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient which is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ke...

The invention relates to a pharmaceutical combination and composition, and in particular to a combination of an analgesic and an anti-inflammatory selected from Ketorolac and Meloxicam or Piroxicam, and pharmaceutically suitable vehicles or excipients. The invention also relates to a method for manufacturing a pharmaceutical composition and to the use of said composition in preparing a medication that can be used to treat pain and inflammation.

This invention relates to therapeutic compositions, particularly sprayable aqueous compositions, and unit dose formulations comprise ketorolac or a pharmaceutically acceptable salt, alone or in combination with lidocaine or a pharmaceutically acceptable salt thereof. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation.

This invention relates to therapeutic compositions particularly sprayable aqueous compositions and unit dose formulations comprise ketorolac or a pharmaceutically acceptable salt alone or in combination with lidocaine or a pharmaceutically acceptable salt thereof. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation.

The present invention is directed to an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose which promotes epithelial wound healing in a patients cornea.